Cell Signaling Technology

DNA Damage Control Cell Extracts

#4768 · $165

100
Citing papers
8.8k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism13Genomics, phytochemicals, and oxidative stress9Wnt/β-catenin signaling in development and cancer9PI3K/AKT/mTOR signaling in cancer8Cancer-related gene regulation7Autophagy in Disease and Therapy6Angiogenesis and VEGF in Cancer6Mitochondrial Function and Pathology5

Papers citing this product

1
An Inherited Heteroplasmic Mutation in Mitochondrial Gene COI in a Patient with Prostate Cancer Alters Reactive Oxygen, Reactive Nitrogen and Proliferation
BioMed Research International·2012·739 cit.·DOI
2
Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair
Journal of Biological Chemistry·2009·507 cit.·DOI
3
The lncRNA Neat1 promotes activation of inflammasomes in macrophages
Nature Communications·2019·505 cit.·DOI
4
Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors
Genes & Development·2010·477 cit.·DOI
5
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Breast Cancer Research·2007·228 cit.·DOI
6
Large-Scale Chondroitin Sulfate Proteoglycan Digestion with Chondroitinase Gene Therapy Leads to Reduced Pathology and Modulates Macrophage Phenotype following Spinal Cord Contusion Injury
Journal of Neuroscience·2014·225 cit.·DOI
7
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells
Cellular Physiology and Biochemistry·2019·204 cit.·DOI
8
WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth
Breast Cancer Research·2009·156 cit.·DOI
9
Kit and FcϵRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells
Blood·2004·156 cit.·DOI
10
Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2
Cell Death and Disease·2017·142 cit.·DOI